<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Clinical Trial Participants Who Receive Placebo to Eventually Receive Vaccine
Image Overlay - Clinical Trial Participants Who Receive Placebo to Eventually Receive Vaccine

Clinical Trial Participants Who Receive Placebo to Eventually Receive Vaccine

Clinical Trial Participants Who Receive Placebo to Eventually Receive Vaccine

Patients enrolled in the Pfizer and BioNTech clinical trial for a COVID-19 vaccine who originally receive a placebo will now be given the preventative vaccine. This will not occur until the U.S. Food and Drug Administration grants the vaccine an emergency use authorization or further regulatory approval, however. Trials are generally blinded so participants do not know whether they are receiving a placebo or treatment – though Pfizer hopes to amend this pending approval from regulatory bodies. Yourway has worked throughout the coronavirus pandemic to ensure drug products are delivered on time and even directly to patients, 24/7.

Back to Index
Media

Upcoming Events

Clinical Trial Supply East Coast 2022

October 19-20, 2022
King of Prussia, PA, USA

Media

Articles

Helping Sponsors Navigate Complex Ancillary Supply Sourcing Challenges with Integrated Services

Open chat
Come chat with us!
Hello! How can I help you?